Live feed
Filing
SC 13G
SC 13G0001535610-20-000122·Hepion Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
HEPION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 426897104
Event date: 2020-11-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,000,420
- Percent of class
- 6.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000122
- Form type
- SC 13G
- Filer
- Hepion Pharmaceuticals, Inc.
- CIK
- CIK 1583771
- Filed
- Dec 02, 2020
- Reporting period
- Nov 25, 2020
- Description
- Schedule 13G beneficial ownership